针对大型激酶活性位点,使用刚性,体积庞大的八面体鲁复合体
Jasna Maksimoska1, Li Feng, Klaus Harms
1The Wistar Institute and University of Pennsylvania, Department of Chemistry, Philadelphia, Pennsylvania 19104, USA.
Journal of the American Chemical Society
|November 1, 2008
概括
研究人员开发了新的复合体,以准大型蛋白激酶ATP结合部位. 这些重的八面体化合物,如Lambda-FL172,有效地抑制PAK1,证明了酶抑制剂设计的新策略.
科学领域:
- 药用化学 医学化学
- 结构生物学 结构生物学
- 无机化学 无机化学 有机化学
背景情况:
- 准蛋白激酶对于治疗各种疾病至关重要.
- 激酶中的大型ATP结合部位对选择性抑制剂设计构成挑战.
- 复合物为药物开发提供独特的结构和电子特性.
研究的目的:
- 介绍一种新的策略,用于开发蛋白质激酶抑制剂,使用重的八面体复合体.
- 设计和合成以为基础的抑制剂,向具有大型ATP结合位点的激酶.
- 阐明这些复杂物在激酶活性位点内的结合机制.
主要方法:
- 通过修改已知的抑制剂支架 (NP309) 来合成八面体鲁复合物 (Lambda-FL172,Lambda-FL411).
- PAK1激酶与伦复合物Lambda-FL172.2的联合结晶.
- 进行X射线晶体学以确定高分辨率的共晶结构 (1.65 Å).
主要成果:
- 使用八面体鲁复合体,成功将GSK3/Pim1抑制剂转化为PAK1抑制剂.
- 兰巴达-FL172的大协调球有效地适应了PAK1的活性部位.
- 共同晶体结构揭示了该复合体如何作为一个"码棒"来区分类似的结合点.
结论:
- 庞大而刚硬的八面体鲁复合体是有效的支架,用于准蛋白质激酶中的大型ATP结合位点.
- 这种方法可以通过利用激酶活性位点的固态差异来设计选择性抑制剂.
- 复合体代表了开发新激酶向治疗的有希望的平台.
相关概念视频
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
01:26Targets for Drug Action: Overview
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
01:26Receptor Tyrosine Kinases
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
01:22EDTA: Chemistry and Properties
Polydentate ligands are most widely used in complexometric titrations because they form more stable complexes with the metal ions than mono- or bidentate ligands due to the chelate effect. Examples of polydentate ligands are ethylenediaminetetraacetic acid (EDTA), crown ethers, and cryptands. The most important feature of optimal polydentate ligands is the ability to form 1:1 complexes in a single-step process. Amino carboxylic acid derivatives are frequently used as complexing agents. EDTA is...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:34Enzymes
Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...